Mitigating factors and metabolic mechanisms in fructose-induced nonalcoholic fatty liver disease: The next challenge

American Journal of Clinical Nutrition

Volumn 96, Issue 5, 2012, Pages 951-952

  Hellerstein, Marc K ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KINEMED INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE;

CALORIC INTAKE; EDITORIAL; EXERCISE; FATTY ACID OXIDATION; GLYCOLYSIS; HUMAN; INSULIN RESISTANCE; LIPOGENESIS; METABOLISM; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PROTEIN INTAKE; SUGAR INTAKE; WEIGHT REDUCTION;

AMINO ACIDS, ESSENTIAL; DIETARY CARBOHYDRATES; DIETARY SUPPLEMENTS; FRUCTOSE; HUMANS; LIPID METABOLISM; LIVER; MALE;

EID: 84867759437     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.049650     Document Type: Editorial

References (11)

1. Brunt EM. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2010;7:195-203.
2. Ong JP, Younossi ZM. Nonalcoholic fatty liver disease (NAFLD) - two decades later: are we smarter about its natural history? Am J Gastroenterol 2003;98:1915-7. (Pubitemid 37185784)
3. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, Okunade A, Klein S. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 2009;106:15430-5.
4. Bray GA. Fructose and risk of cardiometabolic disease. Curr Atheroscler Rep (Epub ahead of print 5 September 2012).
5. Theytaz F, Noguchi Y, Egli L, Campos V, Buehler T, Hodson L, Patterson BW, Nishikata N, Kreis R, Mittendorfer B, et al. Effects of supplementation with essential amino acids on intrahepatic lipid concentrations during fructose overfeeding in humans. Am J Clin Nutr 2012;96:1008-16.
6. Bortolotti M, Kreis R, Debard C, Cariou B, Faeh D, Chetiveaux M, Ith M, Vermathen P, Stefanoni N, Le KA, et al. High protein intake reduces intrahepatocellular lipid deposition in humans. Am J Clin Nutr 2009;90:1002-10.
7. Parks EJ, Hellerstein MK. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr 2000;71:412-33. (Pubitemid 30061218)
8. Hellerstein MK. Carbohydrate-induced hypertriglyceridemia: modifying factors and implications for cardiovascular risk. Curr Opin Lipidol 2002;13:33-40. (Pubitemid 34174627)
9. Hellerstein MK, Schwarz JM, Neese RA. Regulation of hepatic de novo lipogenesis in humans. Annu Rev Nutr 1996;16:523-57. (Pubitemid 26286864)
10. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009;119:1322-34.
11. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005;115:1343-51. (Pubitemid 40629054)